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Tprg, a Gene Predominantly Expressed in Skin, Is a
Direct Target of the Transcription Factor p63
Dario Antonini1, Monica Dentice2, Parvesh Mahtani3, Laura De Rosa1, Giusy Della Gatta4,
Anna Mandinova5, Domenico Salvatore2, Elia Stupka6 and Caterina Missero1
p63 and p73 are highly homologous members of the p53 family that originated by gene duplication at the
invertebrate-to-vertebrate transition. We characterize here a previously unreported gene, Transformation-
related protein 63 regulated (Tprg), located upstream of the p63 gene in the vertebrate genome, with striking
similarity to Transformation related protein 63 regulated like (Tprgl), an uncharacterized gene located upstream
of p73, suggesting that p63/Tprg and p73/Tprgl are embedded in a paralogue region originated from a single
duplication event. Tprg is predominantly expressed in the epithelial compartment of the skin, more abundantly
in differentiated cells. Consistent with its relative higher expression in differentiated keratinocytes, finely tuned
p63 expression levels are required for optimal Tprg expression in primary keratinocytes. p63 is essential for Tprg
expression as shown in p63-knockdown keratinocytes; however, high levels of p63 result in Tprg down-
regulation. p63 directly binds in vivo to a canonical p63-binding site in an evolutionary conserved genomic
region located in Tprg intron 4. This genomic region is sufficient to function as a p63-inducible enhancer in
promoter studies. Thus, we demonstrate that the Tprg gene is predominantly expressed in skin, is physically
associated with the p63 gene during evolution, and directly regulated by p63 through a long-distance enhancer
located within the Tprg locus.
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INTRODUCTION
A number of transcription factors are known to regulate skin
development and differentiation. Among these, p63 is a key
modulator of these processes, as is clearly demonstrated
in vivo by knockout studies. p63/ mice fail to form a
stratified epidermis, resulting in lack of barrier formation,
consequent dehydration, and death within hours after birth
(Mills et al., 1999; Yang et al., 1999).
p63 belongs to the p53 gene family consisting of three
genes, p53, p63, and p73, that share a significant sequence
homology (reviewed by Yang et al., 2002). Each p53 family
member contains a transactivation domain at the amino
terminus, a DNA-binding domain, and an oligomerization
domain. In addition, all family members share some common
functions, and bind to a canonical p53-binding site, thus
controlling the expression of a subset of p53 target genes
(Yang et al., 2002, 2006). The use of alternative promoters
and transcription start sites gives rise to two classes of p63
transcripts, those encoding proteins with an amino-terminal
transactivation domain (TA isoforms) and those encoding
proteins lacking this domain (DN isoforms) (Yang et al.,
1998). Three different carboxyl-termini, designated a, b, and
g, are generated by alternative splicing. The carboxyl-
terminus of p63-a is the longest and contains a sterile
a-motif domain and a transactivation-inhibitory domain (Chi
et al., 1999; Thanos and Bowie, 1999; Serber et al., 2002).
Accordingly, DNp63-a has been shown to act as a repressor
and to display dominant-negative function against both
TAp63 isoforms and p53 (Yang et al., 1998; Ghioni et al.,
2002; Westfall et al., 2003; Chan et al., 2004). However,
DNp63-a also positively regulates the expression of some
target genes, such as integrins and other adhesion-associated
genes (Kurata et al., 2004; Carroll et al., 2006; Truong et al.,
2006), as well as keratin 14 (K14) (Romano et al., 2006).
p63 is predominantly expressed in the basal and spinous
layers of the epidermis, and is downregulated upon
keratinocyte differentiation both in vitro and in vivo (Parsa
et al., 1999; Yang et al., 1999; Liefer et al., 2000; Bamberger
and Schmale, 2001; Pellegrini et al., 2001; Westfall et al.,
2003; Nguyen et al., 2006). In the basal layer, p63 is mainly
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involved in maintaining cell proliferation and cell adhesion
(Koster et al., 2004; Deyoung et al., 2006; Sbisa et al., 2006;
Truong et al., 2006).
As keratinocytes detach from the basement membrane,
they begin a program of terminal differentiation, characteri-
zed by a change in keratin expression from K5/K14 to a
suprabasal pair in the spinous layer (K1/K10). Further
keratinocyte differentiation leads to the expression of
filaggrin, loricrin, and other cornified envelope components
in the granular layer, contributing to the formation of the
cutaneous barrier (reviewed by Fuchs, 1998). It has been
proposed that p63 plays a dual role in keratinocyte
differentiation, as it is required for initiating epithelial
stratification (Koster et al., 2004; Nguyen et al., 2006; Truong
et al., 2006), whereas concurrently it inhibits the expression
of some differentiation markers, at least in part through
transcriptional repression of the Notch effector Hes1 (King
et al., 2003; Nguyen et al., 2006). Interestingly, some p63
direct targets, such as Perp, whose expression in skin requires
p63, are predominantly localized in the suprabasal layers
(Ihrie et al., 2005).
Here, we identify Transformation-related protein 63
regulated (Tprg), a previously uncharacterized gene located
upstream of the genomic locus of p63, whose expression is
regulated by p63. Tprg encodes for a cytoplasmic protein
with a high degree of homology with the gene product of
Transformation related protein 63 regulated like (Tprgl),
located upstream of the p73 gene. Both loci are conserved
throughout vertebrate evolution upstream of p63 and p73,
respectively. Tprg is significantly expressed from embryonic
day 15.5 in a cell type-specific manner in the epidermis and
in the hair follicle in contrast to the ubiquitous expression of
Tprgl. We show that Tprg expression is suppressed by p63
knockdown in mouse primary keratinocytes, and is specifi-
cally affected by knockdown of the DNp63-a isoform.
Interestingly, DNp63-a overexpression also negatively reg-
ulates Tprg, suggesting that a finely tuned p63 activity is
required for optimal Tprg expression. p63, moreover, directly
binds and activates a long-distance enhancer located in a
Tprg intronic region. Taken together, our data indicate that
Tprg is a previously uncharacterized gene, conserved
throughout evolution in proximity of p63, and whose
expression is under direct control of p63.
RESULTS
In vertebrates, p63 and p73 proteins are more closely related
to one another than to p53, owing to a higher percentage of
similarity in the DNA-binding domain as well as the presence
of the sterile a-motif domain, absent in p53 (Saccone et al.,
2002; Yang et al., 2002). As p63 and p73 are known to have
derived from a gene duplication event, we investigated
whether they are embedded in paralogous regions, which
would indicate duplication of nearby genes. Interestingly, an
uncharacterized gene located 260 kb upstream of the p63
gene in mouse, indicated by the full-length cDNA
5430420C16Rik, is highly homologous to another unchar-
acterized gene located 101 kb upstream of the p73 gene,
indicated by the full-length cDNA 1200015A19Rik (Kawai
et al., 2001; Figure 1a). On the basis of the results described
below, we have named the above two transcripts Tprg and
Tprgl, respectively. They are both transcribed in the same
direction as the corresponding p63 and p73 genes, and share
44.1% of identity at the protein level (Figure 1b). p63 and p73
share a comparable percentage of identity (56.6%), suggest-
ing that they have evolved in a parallel manner, and may be
embedded in a paralogue region originated from a single
duplication event.
Tprg is transcribed in a 1,087-bp transcript originally
isolated as a full-length cDNA from 6 days neonate head and
adult female vagina cDNA library (Kawai et al., 2001). Tprgl
is transcribed in a 1,756-bp transcript originally isolated from
a cDNA library of adult male lung (Kawai et al., 2001). To
characterize the expression pattern of the two genes, we
measured their expression in mouse adult tissues by real time
reverse transcriptase–polymerase chain reaction (RT–PCR).
Tprg was specifically expressed in skin, and to a much lesser
extent in tongue and esophagus (Figure 2a). In contrast, Tprgl
was abundantly expressed in all tested tissues (Figure 2b). As
previously reported (Yang et al., 1998; Nakamuta and
Kobayashi, 2003; Cam et al., 2006), p63 was expressed at
high levels in skin, tongue, muscles, and testis, and to a lesser
extent in esophagus and heart (Figure 2c). DNp63 was the
predominant isoform in skin, tongue, and esophagus,
whereas TAp63 was highly expressed in muscle and testis
(Figure 2d). Thus, Tprg expression correlates with DNp63
expression in adult mouse tissues. The Tprg gene is predicted
to encode for a putative protein of 279 amino acids (aa),
whereas the Tprgl gene is predicted to encode for a putative
protein of 266 aa. Both proteins have clear orthologues in 26
annotated vertebrate genomes, including other mammals,
xenopus, chicken, zebrafish, and fugu (Figure 1c), but no
homology in non vertebrate genomes, indicating them as
clearly vertebrate-specific proteins. The putative Tprg and
Tprgl proteins share two highly conserved domains, one in
the central region (78% of identity in 32 aa) and the other at
the carboxyl-terminus of the protein (76% of identity in
29 aa). No known protein domains were found in their
sequences. The central portion of the sequence shares a
significant degree of similarity with members of the Sac
family of phosphoinositide phosphatases in Drosophila
melanogaster (Figure S1); however, the similarity occurs
within uncharacterized protein domains. Moreover, mouse
orthologues of these Drosophila genes exist and they do not
display any similarity to Tprg and Tprgl. In the absence of
specific antibodies, Tprg protein expression was evaluated by
transient transfection of a FLAG-tagged construct. Immuno-
blotting analysis revealed that FLAG-Tprg protein run at an
apparent molecular weight of approximately 36 kDa, con-
sistent with the theoretical molecular weight of the wild-type
protein (31 kDa) (Figure 3a). In mouse primary keratinocytes,
immunofluorescence with anti-FLAG antibodies revealed that
exogenous Tprg protein was localized in the cytoplasm,
whereas being absent from the nucleus (Figure 3b). A similar
localization was observed in both undifferentiated (0 hour)
keratinocytes and in keratinocytes induced to differentiate by
Ca2þ addition at 8 and 24 hours. Thus, Tprg is unlikely to be
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Figure 1. Tprg and Tprgl are evolutionarily conserved genes. (a) Graphic alignment of the p63 genomic locus in different species, and comparison with the
p73 genomic region. The indicated genes are conserved in humans, mouse, and fugu. The arrows indicate the direction of each gene. p63 and Tprg are
flanking genes that are highly homologous to p73 and Tprgl, respectively, (dark gray arrows). (b) Pairwise alignment analysis of mouse Tprg and Tprgl
proteins (left panel) and of p63 and of p73 (right panel) by GraphAlign (Spalding and Lammers, 2004). The graph indicates the percentage of identity in
each aligned region. (c) Multiple protein sequence alignment of Tprg and Tprgl by ClustalW analysis (Thompson et al., 1994), showing a high level of
conservation among several vertebrate sequences. Similar or identical aa are highlighted in gray. Identical aa are indicated by ‘‘*’’; similar aa conserved
in all sequences by ‘‘:’’; and similar aa not conserved in all sequences by ‘‘.’’. Underlined are the two regions with highest degree of identity.
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a structural envelope component, or to participate in the
desmosome or other cell junction formations, as the over-
expressed protein remains soluble in the cytoplasm even
upon Ca2þ induced differentiation.
Because of its specific expression in skin and its overlap
with p63 expression, we investigated Tprg expression in
further details. During embryonic development, expression of
p63 and basal layer K5 and K14 begins early around
embryonic days 8.5–9.5, whereas suprabasal markers start
to be expressed at embryonic day 15.5 (Byrne et al., 1994;
Koster et al., 2004). Real-time RT–PCR and in situ hybridiza-
tion analysis revealed that Tprg was undetectable until
embryonic day 15.5 (Figure 4a, and data not shown). Tprg
expression was detected at embryonic day 17.5 in the
epidermis and in the developing hair follicle (Figure 4b).
Stronger expression was obtained in skin 4 days after birth
(P4) when Tprg was specifically expressed in the epithelial
component of the skin, and it was most prominent in the
differentiated layers of the epidermis (Figure 4b). A similar
pattern of expression was observed in adult mouse skin,
whereas in human skin expression was more broadly
distributed (Figure S2).
Consistent with the pattern of expression in skin, Tprg
mRNA was expressed in both human and mouse primary
keratinocytes (Figure 4c, and data not shown). Using mouse
primary keratinocytes as a model system, we measured the
expression levels of p63, Tprg, K1, and filaggrin under basal
undifferentiated conditions (0), and at different time points
upon Ca2þ -induced differentiation. p63 expression was
reduced by Ca2þ addition, whereas K1 and filaggrin were
induced. K1, however, returned to basal levels by 24 hours
(Figure 4c), consistent with its expression in the spinous layer
but not in the granular layer. In contrast, Tprg was expressed
under basal conditions and was progressively upregulated
upon Ca2þ -induced differentiation (Figure 4c).
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Figure 2. The Tprg gene is predominantly expressed in skin. Real-time RT–PCR analysis of Tprg (a), Tprgl (b), p63 (c), and TA and DNp63 (d) expression in
total RNA prepared from the indicated adult mouse tissues. Values are expressed as relative arbitrary units, after internal normalization for actin mRNA
expression. Each condition was tested in duplicate and the standard error is indicated.
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Figure 3. Tprg encodes for a cytoplasmic protein. (a) Immunoblotting
analysis of the FLAG-Tprg protein transiently transfected in human embryonic
kidney 293 cells. After 24 hours, cell were lysed in sample buffer and run on
12% SDS–PAGE gels. Proteins were detected with anti-FLAG monoclonal
antibodies (upper panel). The molecular weight of the protein standards is
indicated. Protein extracts were normalized using anti-ERK polyclonal
antibodies (lower panel, ERK). (b) FLAG-Tprg was cotransfected with a GFP
construct in mouse primary keratinocytes. Cells were treated with Ca2þ as a
differentiating agent for 8 or 24 hours (8, 24 hours) or left untreated (0 hours).
Forty-eight hours after transfection, immunofluorescence analysis was
performed using an anti-FLAG-specific antibody (Tprg, upper panel). GFP
staining was used to mark transfected cells (GFP, lower panel). FLAG-Tprg
localizes selectively to the cytoplasm, whereas GFP is present both in the
nucleus and cytoplasm. Bar¼ 20mm.
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Given that Tprg and p63 are predominantly expressed in
skin, and their temporal patterns of expression in skin, we
asked whether p63 might control Tprg transcription. To test
this possibility, we measured the expression of Tprg in p63-
knockdown keratinocytes, using previously characterized
total p63-specific short interfering RNA (siRNA) (Antonini
et al., 2006). Forty-eight hours after transfection of p63 siRNA
in mouse primary keratinocytes, a strong reduction of Tprg
expression was observed (Figure 5a). In contrast, all the other
tested genes spanning a genomic region 1.7Mbþ 687 kb
from the p63 gene (Figure 1a) were not affected by p63
knockdown (Figure 5a). Similar results were obtained with a
previously characterized independent p63 siRNA oligonu-
cleotide (data not shown) (Antonini et al., 2006). We then
asked which specific p63 isoform controls Tprg expression by
transfection of isoform-specific siRNA oligonucleotides.
Knockdown of the DNp63 or the a-isoforms strongly inhibited
Tprg expression, whereas knockdown of the TA and
g-isoforms was unable to affect Tprg, both under basal
conditions and upon Ca2þ induced differentiation (Figure 5b;
Figure S3). Thus, DNp63-a is required for proper expression
of the Tprg gene in mouse primary keratinocytes.
To further investigate the regulation of Tprg expression by
DNp63-a, we infected primary keratinocytes with a retrovirus
expressing DNp63-a protein fused to an estrogen-receptor
domain (ERp63) and maintained under basal conditions in an
inactive form (Nguyen et al., 2006). Total RNA was prepared
at early time points after ERp63 activation by tamoxifen
treatment, and Tprg expression was measured by real-time
RT–PCR. Upon DNp63-a activation, Tprg expression was
significantly reduced by ERp63 between 40minutes and
1 hour, suggesting that Tprg is likely to be directly regulated
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Figure 4. Tprg is expressed in the epidermis and in the hair follicle and is more abundant in differentiated keratinocytes. (a) Real-time RT–PCR analysis
of whole-embryo RNA at different time points during embryonic development or in adult skin as indicated. Values are expressed and normalized as in
Figure 3. (b) RNA in situ hybridization of mouse skin sections at embryonic day 17.5 (upper left panel) and at postnatal day 4 (P4, lower left panel, and
right panel) using a digoxygenin-labeled antisense probe for mouse Tprg. The dashed line indicates the dermal–epidermal junction. Similar results were
observed using an independent probe, whereas a Tprg sense probe gave no detectable signal under the same conditions (data not shown). Bars¼ 50 mm
for the left panels, and 10mm for the right panel. (c) Real-time RT–PCR analysis of total RNA extracted from primary mouse keratinocytes at different time
points upon Ca2þ treatment, as indicated (hours), reveals an induction of the Tprg expression upon differentiation, whereas p63 is modestly upregulated at
early time points, and then strongly downregulated. Expression of filaggrin and K1 are shown for comparison. Values are expressed as described in Figure 3.
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by p63 (Figure 5c). Interestingly, DNp63-a activation resulted
in Tprg downregulation rather than induction. DNp63-a
activation is unlikely to repress Tprg due to a generic
squelching effect, in agreement with a global gene expression
analysis, which revealed that most genes that are repressed
by p63 activation are induced by p63 knockdown (Giusy
Della Gatta and Caterina Missero, in preparation). A similar
inhibition of Tprg expression was observed in primary
keratinocytes infected with an adenovirus expressing
DNp63-a (Figure 5d), suggesting that Tprg expression is
finely regulated by DNp63-a in keratinocytes.
Regulation of Tprg expression by p63 could either occur
directly through p63 binding to a Tprg-regulatory sequence or
could be mediated by other mechanisms. To identify
potential p63-binding sites in the Tprg gene, we examined
the entire genomic region containing the Tprg locus for p63-
binding sites, using a recently performed genome-wide
chromatin immunoprecipitation (ChIP)-on-chip analysis in
human carcinoma cells (Yang et al., 2006). The Tprg gene
spans 151 kb in the human genome and has five introns.
Interestingly, two genomic regions located in human Tprg
intron 4 displayed p63-binding activity with a significant
binding score, whereas no p63 binding could be detected in
the Tprg putative proximal promoter or in upstream regions
(up to 50 kb from the transcription start site). Both genomic
regions identified are conserved throughout evolution (Figure
6a, and data not shown); however, only one displays a p53/
p63 consensus sequence that is conserved between human
and chicken (Figure 6b). We proceeded to test whether p63
could bind in vivo to the latter. ChIP was performed using
anti-p63-specific antibodies in human primary keratinocytes,
and amplifying three sequences approximately 500 bp apart
(Figure 6a). Interestingly, p63 specifically bound to the
sequence corresponding to the most highly conserved region
and containing the conserved p63-binding site (Figure 6c).
A strong binding was obtained with the corresponding mouse
sequence in mouse primary keratinocytes, where p63 bound
the Tprg-binding site to a similar extent of as that of a high-
affinity long-distance enhancer (C40 enhancer; Antonini
et al., 2006; Yang et al., 2006; Figure 6d). This genomic
region is likely to contain a functional p63-binding site and
also to function as an enhancer. We tested this possibility by
cloning the conserved genomic region containing the binding
site upstream of a thymidine kinase (TK) minimal promoter
driving the expression of a luciferase gene. Transient
transfection assays in HeLa cells revealed that the Tprg
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Figure 5. Tprg gene expression is controlled by p63. (a) Real-time RT–PCR analysis of total RNA prepared from primary mouse keratinocytes transfected
with siRNA specific for p63 (þ ) or with an siRNA-negative control () reveals a downregulation of Tprg that parallels p63 expression, whereas the other
indicated genes located in the p63 locus are unaffected. Values for each gene are expressed as fold changes versus the siRNA-negative control set to 1.
(b) Analysis of Tprg expression by real-time RT–PCR of total RNA prepared from primary mouse keratinocytes transfected with siRNA specific for p63a,
p63g, TAp63, and DNp63 isoforms, or negative control (c), and either grown under basal conditions (undifferentiated ker.) or induced 0.2mM Ca2þ to
differentiate by for 24 hours (differentiated ker.). Values are expressed as fold changes versus the siRNA-negative control in basal conditions set to 1.
Knockdown efficiency and specificity for all p63 isoforms are shown in Figure S3. (c) Expression profile of Tprg at early time points upon induction of p63
activity. Primary mouse keratinocytes were infected with a retrovirus carrying an ER-DNp63-a fusion protein or empty vector control and subsequently
treated with 20 nM tamoxifen for the indicated times. Total RNA was used for cDNA preparation followed by real-time RT–PCR. Values are expressed as
changes in relative mRNA levels in the ER-p63-expressing versus control keratinocytes. (d) Down-modulation of Tprg mRNA expression by DNp63-a.
Primary mouse keratinocytes were infected with a recombinant adenovirus expressing DNp63-a or a control GFP-expressing adenovirus (c) for 24 hours.
Tprg mRNA levels were quantified by real-time RT–PCR. Values are expressed as relative arbitrary units, after internal normalization for GAPDH. GAPDH,
glycerladehyde-3-phosphate dehydrogenase.
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enhancer activity was positively regulated by p63 in a dose-
dependent manner (Figure 6e). Thus, p63 controls Tprg gene
expression by directly binding to a previously unreported
highly conserved long distance enhancer located at approxi-
mately 100 kb from the putative Tprg transcription start site.
DISCUSSION
Tprg was identified here as a previously uncharacterized
gene physically located upstream of the p63 gene in the
vertebrate genomes, whose expression is regulated by p63.
Tprg encodes for a protein highly homologous to the one
encoded by the Tprgl gene, located upstream of the p73
gene. A Tprg/Tprgl ancestor gene is absent in invertebrates,
including in the invertebrate chordate Ciona intestinalis
(Dario Antonini and Caterina Missero, unpublished observa-
tions). Given the similar percentage of identity at the protein
level between Tprg/Tprgl and p63/p73, and the absence of
genes homologous to Tprg in non-vertebrate genomes, we
propose that Tprg and Tprgl emerged during invertebrate-to-
vertebrate transition of the p53 family, arising from the
segmental duplication of the p63/p73 locus in vertebrates.
The proteins encoded by Tprg and Tprgl are highly
conserved throughout the vertebrate lineage, with long
stretches of aa showing very high conservation across both
Tprg and Tprgl from fish to human. Surprisingly, however,
these proteins do not contain any known protein domains.
Even the most conserved stretches of amino-acid sequence
(the DHWNNE ‘‘signature’’ around amino acid 110 and the
KYDF stretch at amino acid 130) are not explained by any
specific protein feature. Some similarity is observed with
some phosphoinositide phosphatases, and it would be
tempting to speculate a connection between the role of these
proteins in Ca2þ mobilization from intracellular stores, or
intracellular trafficking. The conservation, however, is poor,
and lies outside of any known protein domains. Moreover the
similarity to this family of proteins is more significant in lower
organisms such as Drosophila and Aspergillus, despite the
fact that these proteins do exist in mammalian genomes.
Thus, this significance of this similarity will require further
investigation.
We demonstrate here that p63 is required for Tprg
expression in skin, and that p63 exerts a direct control by
binding in human as well as in mouse to a genomic region in
Tprg intron 4, which acts as a p63-dependent enhancer.
Genome-wide analysis of p63-binding regions by ChIP-on-
chip demonstrated that on average p63-binding sites are
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Figure 6. p63 binds to a highly conserved Tprg intronic region. (a) A 2-kb genomic region located in intron 4 and previously found to bind p63 by
ChIP-on-chip (Yang et al., 2006) is shown (horizontal black bar). Three sequences were selected for amplification to test p63-binding in human and
mouse primary keratinocytes (Tested seq 1–3). The degree of evolutionary conservation is represented by vertical black bars and peaks. (b) A conserved
p63-binding site is located within region 2. The predicted p63-binding site is indicated together with its precise nucleotide sequence: bold nucleotides
correspond to the core nucleotide sequence required for p63-binding (el-Deiry et al., 1992; Barbieri et al., 2005; Ihrie et al., 2005; Antonini et al., 2006;
Nguyen et al., 2006; Yang et al., 2006), while underlined nucleotides are matches in the consensus. Nucleotides identical in all species are indicated by *.
(c) Specific binding of endogenous p63 to the human Tprg regions. Human primary keratinocytes under growing conditions were processed for ChIP with
antibodies specific for p63 (þ ), or unrelated anti-ERK1 antibodies as control (), followed by real-time PCR amplification of various regions of the Tprg intronic
sequences indicated in the schematic above. Unprecipitated chromatin preparations were similarly analyzed and used as ‘‘input’’ control. The amount of
precipitated DNA was calculated relative to the total input chromatin, and expressed as the percentage of the total (Frank et al., 2001). (d) Specific binding
of endogenous p63 to the mouse Tprg region corresponding to the human conserved binding site (Tprg) and to the previously characterized C40 enhancer
used as control (Antonini et al., 2006). ChIP was performed as described in (c). (e) The Tprg enhancer is responsive to p63. The Tprg putative enhancer
region was cloned in front of a TK minimal promoter that drives the expression of the luciferase reporter. The construct was transiently transfected into
HeLa cells in the absence () or in the presence of various concentrations of an expression construct for DNp63-g as indicated (in mg). The activity of the
enhancer was measured by luciferase assays and values are expressed relative to () set to 1.
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38.6% nucleotide-identical between human and mouse
(Yang et al., 2006). The p63-binding site in the Tprg intron
4 is conserved in mammals and in chicken, and is more than
90% identical between human and mouse, thus being among
the most conserved binding regions identified to date.
Interestingly, we identify that p63 binds to several other
highly conserved binding sites in the genomic region
encompassing Tprg and p63 (Antonini et al., 2006; Yang
et al., 2006, and Dario Antonini and Caterina Missero,
unpublished data), and their functional relevance will require
further investigation.
Although p63 is required for Tprg expression, Tprg starts to
be expressed in embryonic skin much later than p63, and unlike
p63, it is more abundant in differentiated keratinocytes, at least
in the developing and newborn skin, suggesting either that other
transcription factors may be involved in Tprg expression in the
suprabasal compartment, or that a balance between different
p63 isoforms may trigger Tprg expression. The expression and
putative function of the various p63 isoforms in skin is
controversial. It has been proposed that during embryogenesis
DNp63-a is required to counterbalance the inhibitory effect of
TAp63-a on terminal differentiation (Koster et al., 2004).
However, DNp63 isoforms are highly expressed even before
epidermal stratification, whereas the TAp63 isoforms are
expressed at very low levels (Laurikkala et al., 2006). Similarly,
in normal human and mouse epidermis, DNp63-a is the most
abundant p63 splice variant, whereas very weak expression of
TAp63-a and DNp63-g is detected at the RNA but not at the
protein level (Bamberger et al., 2002, 2005). In primary
keratinocytes, DNp63-a is readily detectable at the protein
level under proliferating conditions, and declines upon
Ca2þ -induced differentiation. The onset of differentiation in
human keratinocytes does not change the ratio of two other
very weakly expressed isoforms (Bamberger et al., 2002). In
mouse keratinocytes, it has been reported that the TAp63-g
isoform is induced upon Ca2þ addition (King et al., 2006),
although under our culture conditions, we could not detect
any significant change in TAp63 expression during differ-
entiation (data not shown). Our knockdown studies clearly
demonstrate that Tprg expression is dependent on DNp63-a,
whereas the TAp63 and p63-g isoforms do not alter Tprg
expression under proliferating or differentiating conditions.
Consistent with these data, Tprg expression in the adult
mouse follows the tissue distribution of DNp63, whereas it is
not expressed in tissues where TAp63 is abundant.
In contrast to p63, Tprg expression in skin and in isolated
keratinocytes is higher in differentiated keratinocytes than in
basal keratinocytes. Accordingly, p63 is required for Tprg
expression in keratinocytes (Figure 5a and b), but high levels
of p63 results in Tprg downregulation (Figure 5c and d),
suggesting that optimal Tprg expression may require levels of
p63 expression lower than those present in the basal layer.
Thus, DNp63-a finely regulates Tprg expression possibly in
conjunction with other transcription factors.
In conclusion, we have identified Tprg as a gene,
predominantly expressed in skin, likely to be co-regulated
with its adjacent gene p63. We have shown that p63
participates directly in the transcriptional control of Tprg
expression in skin. Tprg gene and its paralogue Tprgl encode
for proteins, which are specific to the vertebrate lineage and
highly conserved in sequence; however, their functions will
require further investigation.
MATERIALS AND METHODS
Cell cultures, transfections, and reporter assays
Mouse primary keratinocytes were isolated from 2-day-old Swiss
CD1 mice and cultured under low-Ca2þ conditions (0.05mM) in the
presence of 4% Ca2þ -chelated fetal bovine serum (Invitrogen,
Carlsbad, CA), and epidermal growth factor (Invitrogen), as
previously described (Antonini et al., 2006). Terminal differentiation
was induced by addition of 0.2mM calcium chloride to the medium.
Human primary keratinocytes were kindly provided by Dr GP Dotto,
and cultured in keratinocyte-serum-free medium medium supple-
mented with bovine pituitary extracts and epidermal growth factor
(Invitrogen). Human embryonic kidney 293 and HeLa cells were
cultured in Dulbecco’s modified Eagle’s medium with 10% fetal
bovine serum. All cell types were transfected using Lipofectamine
2000 (Invitrogen) following the manufacturer’s protocol. Confluent
mouse primary keratinocytes were transfected 5 days after plating.
Keratinocytes in 60-mm dishes were transfected with 2 mg of
pCMV2-FLAG-Tprg and pCMV2-FLAG (control) together with
0.2 mg of pCMV–GFP (green-fluorescent protein; Clontech, Palo
Alto, CA), or with 200mM of stealth siRNA for mouse p63-a, -g,
DNp63, Tap63, or an siRNA recognizing all isoforms (Antonini et al.,
2006; Supplementary Material), or a control medium GC-rich stealth
siRNA (Invitrogen).
HeLa cells in 12-well dishes were transfected with a construct
carrying the Tprg enhancer and the TK minimal promoter driving the
expression of the luciferase gene (see below) (0.25 mg); the DNp63-g
(0.05 and 0.1 mg); and CMV–Renilla (0.02 mg; Promega, Madison,
WI). Luciferase activity was determined 48 hours after transfection
with the dual-luciferase reporter assay kit (Promega). Renilla
luciferase activity was used to normalize transfection efficiency.
Plasmids and constructs
For the retrovirus expressing inducible p63, a modified ER ligand-
binding domain (Littlewood et al., 1995) was cloned in frame
between the FLAG epitope and the DNp63-a cDNA lacking the first
ATG, and inserted into the HindIII–NotI sites under the control of the
CMV promoter in the PINCO retroviral vector (Nocentini et al.,
1997). The pCMV2-FLAG Tprg expression vector was obtained by
amplifying the putative coding sequence of Tprg lacking the ATG
from mouse primary keratinocyte cDNA using the PfuI polymerase
(Stratagene, La Jolla, CA) with specific oligonucleotide primers (see
Supplementary Material), and by cloning it in frame in pCMVFLAG2
(Sigma, St. Louis, MO) in NotI–XbaI. The construct was sequence
verified and tested by immunoblotting for its ability to encode for a
protein. The Tprg enhancer sequence (597 bp) was amplified by PCR
from mouse genomic DNA using specific oligonucleotide primers
(see Supplementary Material), and cloned in the pGL3-TK-Luc
construct (Ohno et al., 1999) at the KpnI site. The enhancer
sequence was verified by sequencing.
Real-time RT–PCR and microarray
Mouse embryos and adult tissues derived from adult CD1 female
mice were snap frozen, pulverized, and dissolved in TRIzol reagent
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(Invitrogen) for RNA preparation according to manufacturer’s
protocol. RNA samples were treated with RNase-free DNaseI
(Promega). cDNA was synthesized using Superscript III (Invitrogen).
Two-step real-time RT–PCR was performed using the SYBR Green
PCR core kit (Applied Biosystems, Foster City, CA). Expression of the
endogenous Tprg transcript, as well as of the other target genes, was
quantified using specific oligonucleotide primers (see Supplemen-
tary Material).
Immunostaining and immunoblotting
Forty-eight hours after transfection, mouse primary keratinocytes
were fixed in methanol for 5minutes at 20 1C, washed in
phosphate-buffered saline (PBS), and permeabilized in 0.2%
Triton/PBS. Fixed cells were incubated with anti-FLAG biotinylated
antibodies (BioM2, 1:100; Sigma) in 0.1% Triton/5% goat serum/PBS
for 1 hour at room temperature. After extensive washing in 0.1%
Triton/PBS, cells were incubated with streptavidin Cy3 (1:100;
Sigma), washed, and stained with 4’,6-diamidino-2-phenylindole at
100 ngml1 in PBS. Slides were mounted using Vectashield as
mounting reagent (Vector Laboratories, Burlingame, CA), and
examined under an Axioplan imaging microscope (Zeiss, Micro
Imaging, Thornwood, NY).
For immunoblotting, human embryonic kidney 293 cells plated
in 60-mm dishes were transfected with 4mg of pCMV2-FLAG Tprg or
empty vector as control. Cells were lysed in sample buffer 24 hours
after transfection. Protein extracts (10 mg) were run on 12%
SDS–PAGE and transferred on an Immobilon-P transfer membrane
(Millipore, Bedford, MA). The membrane was probed with anti-Flag
monoclonal antibodies (M5, Sigma), or with anti-extracellular
signal-regulated kinase (ERK) antibodies (Santa Cruz Biotechnology,
Santa Cruz, CA) as loading control.
In situ hybridization
Skin was fixed in 4% fresh paraformaldehyde overnight at 4 1C,
washed in PBS, incubated in 30% sucrose/PBS overnight at 4 1C, and
embedded in OCT compound (Sakura, Torrance, CA). In situ
hybridization was performed as described previously (Brancaccio
et al., 2004). Hybridization was performed with 1mgml1 of
digoxygenin-labeled Tprg cRNA probe corresponding to a cDNA
fragment of 511 bp of coding sequence (see Supplementary
Material), and cloned into pCR2.1-TOPO vector. Antisense and
sense probes were transcribed from the T3 and T7 promoters,
respectively, using a digoxygenin labeling kit (Roche, Basel,
Switzerland) as described by manufacturer’s instructions. Mice were
housed and treated according to the guidelines of the local
Institutional Animal Care and Use Committee. This study was
conducted under approval of the Institutional Review Board and
according to the Declaration of Helsinki Principles. Written
informed consent was obtained from the human skin donors.
Chromatin immunoprecipitation
Approximately 3 106 mouse keratinocytes were fixed with 1%
formaldehyde in growth medium at 37 1C for 10minutes. Extracts
were extensively sonicated on ice to obtain DNA fragments ranging
from 200 to 800 bp in length. Chromatin was immunoprecipitated
following the Upstate protocol (http://www.upstate.com). Immuno-
precipitation was performed using anti-p63 (H-137; Santa Cruz
Biotechnology) and anti-ERK-1 (K23; Santa Cruz Biotechnology)
antibodies. Real-time PCR was performed using the SYBR Green
PCR master mix in an ABI PRISM 7000 (Applied Biosystems), using
specific oligonucleotide sequences (see Supplementary Material).
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
This manuscript is dedicated to the memory of Parvesh Mahtani. We thank
Tommaso Russo and Nicola Zambrano for critical reading of the manuscript
and Diego Di Bernardo for helpful discussion. We also thank Annie Yang and
co-workers for sharing ChIP-on-chip data before publication. DA is a PhD
student at the European School of Molecular Medicine (SEMM), LDR is a PhD
student at Genetics and Molecular Medicine of the University ‘‘Federico II’’,
and GDG is a PhD student in Medical Genetics of the Second University of
Napoli, Italy. This work was supported by grants from the European Union
(LSHG-CT-2004-511990), the Italian Telethon Foundation (GGP06243), and
the NIH (AR-01-004).
SUPPLEMENTARY MATERIAL
Supplementary Materials.
Figure S1. The TPRG central hydrophobic domain shares a significant degree
of similarity with an uncharacterized region of the phosphoinositide
polyphosphatases of the Sac family.
Figure S2. Tprg expression in mouse and human adult skin.
Figure S3. Knockdown of the p63-specific isoforms in mouse primary
keratinocytes under basal and differentiating conditions.
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